An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cells
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in STAR Protocols
- Vol. 2 (1) , 100213
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 18 references indexed in Scilit:
- The Rho-associated kinase inhibitor fasudil can replace Y-27632 for use in human pluripotent stem cell researchPLOS ONE, 2020
- Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditionsNature Communications, 2020
- Post-Passage rock inhibition induces cytoskeletal aberrations and apoptosis in Human embryonic stem cellsStem Cell Research, 2019
- Deep phenotyping of human induced pluripotent stem cell–derived atrial and ventricular cardiomyocytesJCI Insight, 2018
- Chemically defined generation of human cardiomyocytesNature Methods, 2014
- Continuous Hypoxic Culturing of Human Embryonic Stem Cells Enhances SSEA-3 and MYC LevelsPLOS ONE, 2013
- Hypoxia induces re-entry of committed cells into pluripotencyStem Cells, 2013
- Culture under low physiological oxygen conditions improves the stemness and quality of induced pluripotent stem cellsJournal of Cellular Physiology, 2013
- Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensionsReproduction, 2010
- Hypoxia Enhances the Generation of Induced Pluripotent Stem CellsCell Stem Cell, 2009